A citation-based method for searching scientific literature

James J Hsieh, Mark P Purdue, Sabina Signoretti, Charles Swanton, Laurence Albiges, Manuela Schmidinger, Daniel Y Heng, James Larkin, Vincenzo Ficarra. Nat Rev Dis Primers 2017
Times Cited: 868







List of co-cited articles
344 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
14

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Brian I Rini, Elizabeth R Plimack, Viktor Stus, Rustem Gafanov, Robert Hawkins, Dmitry Nosov, Frédéric Pouliot, Boris Alekseev, Denis Soulières, Bohuslav Melichar,[...]. N Engl J Med 2019
11

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
11

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Börje Ljungberg, Laurance Albiges, Yasmin Abu-Ghanem, Karim Bensalah, Saeed Dabestani, Sergio Fernández-Pello, Rachel H Giles, Fabian Hofmann, Milan Hora, Markus A Kuczyk,[...]. Eur Urol 2019
556
10

Epidemiology of Renal Cell Carcinoma.
Umberto Capitanio, Karim Bensalah, Axel Bex, Stephen A Boorjian, Freddie Bray, Jonathan Coleman, John L Gore, Maxine Sun, Christopher Wood, Paul Russo. Eur Urol 2019
397
10

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Holger Moch, Antonio L Cubilla, Peter A Humphrey, Victor E Reuter, Thomas M Ulbright. Eur Urol 2016
10

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Robert J Motzer, Nizar M Tannir, David F McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Toni K Choueiri, Elizabeth R Plimack, Philippe Barthélémy, Camillo Porta, Saby George,[...]. N Engl J Med 2018
9

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Toni K Choueiri, Thomas Powles, Mauricio Burotto, Bernard Escudier, Maria T Bourlon, Bogdan Zurawski, Victor M Oyervides Juárez, James J Hsieh, Umberto Basso, Amishi Y Shah,[...]. N Engl J Med 2021
233
8

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
8

Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.
Thomas Powles, Elizabeth R Plimack, Denis Soulières, Tom Waddell, Viktor Stus, Rustem Gafanov, Dmitry Nosov, Frédéric Pouliot, Bohuslav Melichar, Ihor Vynnychenko,[...]. Lancet Oncol 2020
147
7

Epidemiology of Renal Cell Carcinoma.
Sandeep Anand Padala, Adam Barsouk, Krishna Chaitanya Thandra, Kalyan Saginala, Azeem Mohammed, Anusha Vakiti, Prashanth Rawla, Alexander Barsouk. World J Oncol 2020
110
7

Treatment of renal cell carcinoma: Current status and future directions.
Pedro C Barata, Brian I Rini. CA Cancer J Clin 2017
294
7

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
B Escudier, C Porta, M Schmidinger, N Rioux-Leclercq, A Bex, V Khoo, V Grünwald, S Gillessen, A Horwich. Ann Oncol 2019
225
7

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
Taiwen Li, Jingyu Fan, Binbin Wang, Nicole Traugh, Qianming Chen, Jun S Liu, Bo Li, X Shirley Liu. Cancer Res 2017
7

Inferring tumour purity and stromal and immune cell admixture from expression data.
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez, Rahulsimham Vegesna, Hoon Kim, Wandaliz Torres-Garcia, Victor Treviño, Hui Shen, Peter W Laird, Douglas A Levine,[...]. Nat Commun 2013
7

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
7

Systemic Therapy for Metastatic Renal-Cell Carcinoma.
Toni K Choueiri, Robert J Motzer. N Engl J Med 2017
580
6

Epidemiology and risk factors for kidney cancer.
Wong-Ho Chow, Linda M Dong, Susan S Devesa. Nat Rev Urol 2010
822
6

Integrated molecular analysis of clear-cell renal cell carcinoma.
Yusuke Sato, Tetsuichi Yoshizato, Yuichi Shiraishi, Shigekatsu Maekawa, Yusuke Okuno, Takumi Kamura, Teppei Shimamura, Aiko Sato-Otsubo, Genta Nagae, Hiromichi Suzuki,[...]. Nat Genet 2013
674
6

The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
W Marston Linehan, Christopher J Ricketts. Nat Rev Urol 2019
143
6

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, Ming Liu, Eliezer M Van Allen, Guillermo de Velasco, Diana Miao, Irina Ostrovnaya, Esther Drill, Augustin Luna,[...]. Genome Biol 2016
375
6

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.
Eric Jonasch, Cheryl Lyn Walker, W Kimryn Rathmell. Nat Rev Nephrol 2021
46
13

Cytoscape: a software environment for integrated models of biomolecular interaction networks.
Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, Trey Ideker. Genome Res 2003
5

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Robert Motzer, Boris Alekseev, Sun-Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Evgeny Kopyltsov, María J Méndez-Vidal,[...]. N Engl J Med 2021
219
5

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial.
Laurence Albiges, Nizar M Tannir, Mauricio Burotto, David McDermott, Elizabeth R Plimack, Philippe Barthélémy, Camillo Porta, Thomas Powles, Frede Donskov, Saby George,[...]. ESMO Open 2020
96
5

Kidney Cancer: An Overview of Current Therapeutic Approaches.
Nivedita Chowdhury, Charles G Drake. Urol Clin North Am 2020
32
15

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Robert J Motzer, Thomas E Hutson, Piotr Tomczak, M Dror Michaelson, Ronald M Bukowski, Olivier Rixe, Stéphane Oudard, Sylvie Negrier, Cezary Szczylik, Sindy T Kim,[...]. N Engl J Med 2007
5

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
Gary Hudes, Michael Carducci, Piotr Tomczak, Janice Dutcher, Robert Figlin, Anil Kapoor, Elzbieta Staroslawska, Jeffrey Sosman, David McDermott, István Bodrogi,[...]. N Engl J Med 2007
5

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
Toni K Choueiri, Bernard Escudier, Thomas Powles, Paul N Mainwaring, Brian I Rini, Frede Donskov, Hans Hammers, Thomas E Hutson, Jae-Lyun Lee, Katriina Peltola,[...]. N Engl J Med 2015
701
5

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Robert J Motzer, Konstantin Penkov, John Haanen, Brian Rini, Laurence Albiges, Matthew T Campbell, Balaji Venugopal, Christian Kollmannsberger, Sylvie Negrier, Motohide Uemura,[...]. N Engl J Med 2019
5

HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.
Weinan Du, Luchang Zhang, Adina Brett-Morris, Brittany Aguila, Janos Kerner, Charles L Hoppel, Michelle Puchowicz, Dolors Serra, Laura Herrero, Brian I Rini,[...]. Nat Commun 2017
149
5


Metabolic reprogramming in clear cell renal cell carcinoma.
Hiromi I Wettersten, Omran Abu Aboud, Primo N Lara, Robert H Weiss. Nat Rev Nephrol 2017
136
5

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
David J Clark, Saravana M Dhanasekaran, Francesca Petralia, Jianbo Pan, Xiaoyu Song, Yingwei Hu, Felipe da Veiga Leprevost, Boris Reva, Tung-Shing M Lih, Hui-Yin Chang,[...]. Cell 2019
158
5

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.
David A Braun, Yue Hou, Ziad Bakouny, Miriam Ficial, Miriam Sant' Angelo, Juliet Forman, Petra Ross-Macdonald, Ashton C Berger, Opeyemi A Jegede, Liudmilla Elagina,[...]. Nat Med 2020
134
5

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
5

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
5

Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis.
Francesco Massari, Veronica Mollica, Alessandro Rizzo, Laura Cosmai, Mimma Rizzo, Camillo Porta. Expert Opin Drug Saf 2020
39
10

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC).
Brian I Rini, Dena Battle, Robert A Figlin, Daniel J George, Hans Hammers, Tom Hutson, Eric Jonasch, Richard W Joseph, David F McDermott, Robert J Motzer,[...]. J Immunother Cancer 2019
95
4

Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
Michael L Nickerson, Erich Jaeger, Yangu Shi, Jeffrey A Durocher, Sunil Mahurkar, David Zaridze, Vsevolod Matveev, Vladimir Janout, Hellena Kollarova, Vladimir Bencko,[...]. Clin Cancer Res 2008
378
4


Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
4

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.
Robert J Motzer, Bernard Escudier, Stéphane Oudard, Thomas E Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A Thompson, Robert A Figlin, Norbert Hollaender,[...]. Lancet 2008
4

Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
Robert J Motzer, Thomas E Hutson, David Cella, James Reeves, Robert Hawkins, Jun Guo, Paul Nathan, Michael Staehler, Paul de Souza, Jaime R Merchan,[...]. N Engl J Med 2013
4

Targeting renal cell carcinoma with a HIF-2 antagonist.
Wenfang Chen, Haley Hill, Alana Christie, Min Soo Kim, Eboni Holloman, Andrea Pavia-Jimenez, Farrah Homayoun, Yuanqing Ma, Nirav Patel, Paul Yell,[...]. Nature 2016
364
4

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.
Robert J Motzer, Thomas E Hutson, Hilary Glen, M Dror Michaelson, Ana Molina, Timothy Eisen, Jacek Jassem, Jakub Zolnierek, Jose Pablo Maroto, Begoña Mellado,[...]. Lancet Oncol 2015
505
4

Systemic treatment of renal cell cancer: A comprehensive review.
Amparo Sánchez-Gastaldo, Emmanuelle Kempf, Aránzazu González Del Alba, Ignacio Duran. Cancer Treat Rev 2017
77
5

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Samra Turajlic, Hang Xu, Kevin Litchfield, Andrew Rowan, Stuart Horswell, Tim Chambers, Tim O'Brien, Jose I Lopez, Thomas B K Watkins, David Nicol,[...]. Cell 2018
251
4

HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.
Bo Qiu, Daniel Ackerman, Danielle J Sanchez, Bo Li, Joshua D Ochocki, Alison Grazioli, Ekaterina Bobrovnikova-Marjon, J Alan Diehl, Brian Keith, M Celeste Simon. Cancer Discov 2015
177
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.